Pharmacokinetic interaction of tetracycline with centchroman in healthy female volunteers

Drugs in R and D

Volumn 4, Issue 5, 2003, Pages 293-299

  Khurana, Manoj ^a   Lal, Jawahar ^a   Kamboj, Ved P ^a   Nityanand, Swaran ^a   Gupta, Ram C ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CENTCHROMAN; ORAL CONTRACEPTIVE AGENT; RESTECLIN; TETRACYCLINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BACTERIAL SPORE; BLOOD; BLOOD SAMPLING; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INTERACTION; DRUG METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LACTIC ACID BACTERIUM; LACTOBACILLUS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; TABLET FORMULATION; TIME;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; CENTCHROMAN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONTRACEPTIVES, ORAL; DRUG INTERACTIONS; FEMALE; HUMANS; LACTOBACILLUS; SINGLE-BLIND METHOD; SPORES, BACTERIAL; TETRACYCLINE; TIME FACTORS;

EID: 0141727520     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200304050-00003     Document Type: Article

References (28)

1. Ray S, Grover PK, Anand N. New synthesis of cis- and trans-3-phenyl-4-[4-(β-pyrolidinoethoxy) phenyl]-7-methoxy chromans. Indian J Chem 1971; 9: 727-8
2. Singh MM. Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders. Med Res Rev 2001; 21: 302-47
3. Kamboj VP, Ray S, Dhawan BN. Centchroman. Drugs Today (Barc) 1992; 28: 227-32
4. Indian Pharmacopoeia. Ormeloxifene hydrochloride. Delhi: Controller of Publications, 1996: 539-40
5. Misra NC, Nigam PK, Gupta R. Centchroma: a non-steroidal anticancer agent for advanced breast cancer: phase II study. Int J Cancer 1989; 43: 781-3
6. Labroo VM, Piggott JR, Bain SD. Methods for reducing bone loss using centchroman derivatives. US patent 5464862, 1995
7. Nityanad S. Centchroman: current status as a contraceptive. Proc X Indian Conf Family Welfare Voluntary Sterilization; JIPMER, Pondicherry, India, 1994: 41-2
8. Nityanad S, Anand N. Centchroman: a nonsteroidal antifertility agent. FOGSI (Fed Obstet Gynaecol Soc, India) FOCUS 1996, 8-10
9. Nityanad S, Wati C, Singh L, et al. Clinical evaluation of centchroman: a new oral contraceptive. In: Puri CP, Van Look PFA, editors. Hormone antagonists for fertility control and regulation. India: Indian Society for the Study of Reproduction and Fertility, 1988: 223-30
10. Lal J, Asthana OP, Nityanand S, et al. Pharmacokinetics of centchroman in healthy female subjects after oral administration. Contraception 1995; 52: 297-300
11. Paliwal JK, Gupta RC, Grover PK, et al. High performance liquid chromatography determination of centchroman in human serum an application to single-dose pharmacokinctics. Pharm Res 1989; 6: 1048-51
12. Reynolds JEF, editor. Martindale Extra Pharmacopoeia. London: Royal Pharmaceutical Society, 1996: 285-88
13. Reynolds JEF, editor. Martindale Extra Pharmacopoeia. London: Royal Pharmaceutical Society, 1996: 1718-19
14. Murphy A, Zacur HA, Charache P, et al. The effect of tetracycline on oral contraceptives. Am J Obstet Gynecol 1991; 164: 28-33
15. McLone DG, Billings TE, Hardegree WE, et al. Gonorrhoea in females treated with one oral dose of tetracycline. Br J Vener Dis 1968; 44: 218-9
16. Stockley IH. Antibiotics and oral contraceptive failure: an update. J Pharmacol 1982; 6: 525-8
17. Back DJ, Grimmer SFM, Orme ML'E, et al. Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics. Br J Clin Pharmacol 1988; 25: 527-32
18. Weisberg E. Interactions between oral contraceptives and antifungals/antibacterials: is contraceptive failure the result? Clin Pharmacokinet 1999; 36: 309-13
19. Ghosh R, Kamboj VP, Singh MM. Interaction with anti-implantation and estrogen antagonistic activities of dl-ormeloxifene, a selective estrogen receptor modulator, by tetracycline in female Sprague-Dawley rats. Contraception 2001; 64: 261-9
20. Khurana M, Lal J, Singh MM, et al. Evaluation of interaction potential of certain concurrently administered drugs with pharmacological and pharmacokinetic profile of centchroman in rats. Contraception 2002; 66: 47-56
21. Weaver K, Glasier A. Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill. Contraception 1999; 59: 71-8
22. Davies DM. Textbook of adverse drug reactions. USA: Oxford University Press, 1986: 233-49
23. Lal J, Paliwal JK, Grover PK, et al. Simultaneous liquid chromatography determination of centchroman and its 7-demethylated metabolite in serum and milk. J Chromatogr B 1994; 658: 193-7
24. Batt RM, Rutgers HC, Sancak AA. Enteric bacteria: friend or foe? J Small Anim Pract 1996; 37: 261-7
25. Simon GL, Gorbach SL. The human intestinal microflora. Dig Dis Sci 1986; 31: 147S-62S
26. Obach RS, Baxter JT, Listen TE, et al. Prediction of human pharmacokinetic parameters from pre-clinical and in vitro metabolism data. J Pharmacol Exp Ther 1997; 283: 46-8
27. Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res 1993; 10: 1093-5
28. Lal J, Nityanand S, Asthana OP, et al. Comparative biavailability of two commercial centchroman tablets in healthy female subjects. Indian J Pharmacol 1996; 28: 32-4